The British Journal of Psychiatry · 1980 · 175 citations · 32 references
Life SciencesNeurosciencePsychiatryNeurochemistryNeuropsychiatryPsychopharmacologyCerebrospinal Fluid BiomarkersMonoamine NeurochemistryEtiology Of Psychotic DisordersFamily History Of PsychosisFamily Involvement In DispositionFamily VulnerabilityMonoamine Metabolism
In 60 physically and mentally healthy human subjects, lumbar cerebrospinal fluid was analysed by mass fragmentography for 5-HIAA, HVA and MOPEG. Individuals with a family history of psychiatric morbidity had significantly greater variation in monoamine metabolite concentrations than subjects without such a family history. In subjects with a family history of schizophrenic psychosis 5-HIAA and HVA concentrations were significantly higher than in subjects with depressive disorders within the family. For subjects with deviant 5-HIAA levels the probability of having a psychiatric family history was 2.7 times higher than in subjects with normal values. For HVA and MOPEG similar relationships, but of a lower significance level, were found. The results suggest that the cerebral monoaminergic transmitter amines play critical roles in the pathophysiology of psychotic and depressive disorders with a family disposition. They also indicate a value of monoamine metabolite determination in CSF for the prediction of family vulnerability for psychiatric morbidity in healthy subjects.
32
5-HIAA in the Cerebrospinal Fluid
Marie Åsberg · Archives of General Psychiatry · 1976 · 1.4K citations
Statistical Methods for Rates and Proportions.
F. N. D., J. L. Fleiss · Biometrics · 1973 · 1.4K citations
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Marie Åsberg, Peter Thorén, Lil Träskman et al. · Science · 1976 · 679 citations
Medicine, Pharmacology, Psychiatry +17
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
Arvid Carlsson · American Journal of Psychiatry · 1978 · 498 citations
Medicine, Pharmacology, Psychiatry +17